The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 14, 2012

Filed:

Nov. 02, 2007
Applicants:

Henry Klassen, Pasadena, CA (US);

Michael Schwartz, Garden Grove, CA (US);

Michael J. Young, Gloucester, MA (US);

Inventors:

Henry Klassen, Pasadena, CA (US);

Michael Schwartz, Garden Grove, CA (US);

Michael J. Young, Gloucester, MA (US);

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/0797 (2010.01); C12N 5/079 (2010.01); C12N 5/074 (2010.01);
U.S. Cl.
CPC ...
Abstract

During the growth and study of NSCs, a range of molecules present on the surface of multipotent neural stem and progenitor cells (NSCs) were identified. These markers were identified using a number of human and murine neural stem cell lines, including retinal stem cells (RSCs). The NSC-specific markers identified included gene products as well as non-protein molecules and sugar epitopes not directly coded in the genome. Together with surface markers which were determined to be absent from the surface of hNSCs, the molecules described herein provide a means to enrich for neural stem cells, or neural progenitor subpopulations, particularly using combinatorial cell sorting strategies. These same molecules also represent targets for pharmacological manipulation of NSC populations and subpopulations, both in vivo and ex vivo. Furthermore, these molecules provide potential targets for therapeutic manipulation of other neural precursor-related cell types including malignant conditions as well as other diseases originating from, or preferentially affecting, various uncommitted or replication-competent cell types.


Find Patent Forward Citations

Loading…